$3.92
0.267.10%
At Close: -
$3.81
-0.11-2.81%
After Hours: 7:55 PM EDT
15 minutes delayed
Comments
Loading...
Vistagen Therapeutics
VTGNNASDAQ
Vistagen Therapeutics (NASDAQ:VTGN) Stock, Earnings Estimates, EPS, And Revenue
Vistagen Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS Estimate
$-0.400
Quarterly Revenue Estimate
$300K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$1.1M
Analyze the earnings history of Vistagen Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VTGN | VistaGen Therapeutics | -$0.94 | -$0.40 | — | — | $177.60K | $300.00K | — | — | 08/08/2024 | Get Alert |
| VTGN | VistaGen Therapeutics | -$1.61 | -$0.37 | -$0.25 | 32.43% | $175.60K | $410.00K | $197.30K | -51.88% | 06/11/2024 | Get Alert |
| VTGN | VistaGen Therapeutics | -$1.42 | -$0.30 | -$0.22 | 26.67% | $179.60K | $540.00K | $411.40K | -23.81% | 02/13/2024 | Get Alert |
| VTGN | VistaGen Therapeutics | -$2.40 | -$0.68 | -$0.66 | 2.94% | -$892.50K | $180.00K | $277.70K | 54.28% | 11/09/2023 | Get Alert |
| VTGN | VistaGen Therapeutics | -$3.00 | — | -$0.94 | — | $310.10K | — | $177.60K | — | 08/10/2023 | Get Alert |
| VTGN | VistaGen Therapeutics | -$2.70 | — | -$1.61 | — | $38.90K | — | $175.60K | — | 06/28/2023 | Get Alert |
| VTGN | VistaGen Therapeutics | -$1.50 | -$2.10 | -$1.50 | 28.57% | $357.90K | $150.00K | $179.60K | 19.73% | 02/07/2023 | Get Alert |
| VTGN | VistaGen Therapeutics | -$2.10 | -$2.10 | -$2.40 | -14.29% | $358.00K | $310.00K | -$892.50K | -387.90% | 11/10/2022 | Get Alert |
| VTGN | VistaGen Therapeutics | -$1.20 | -$2.10 | -$3.00 | -42.86% | $354.10K | — | $310.10K | — | 08/11/2022 | Get Alert |
| VTGN | VistaGen Therapeutics | -$9.00 | -$1.80 | -$2.70 | -50.00% | $441.90K | $350.00K | $38.90K | -88.89% | 06/23/2022 | Get Alert |
| VTGN | VistaGen Therapeutics | -$2.10 | -$2.10 | -$1.50 | 28.57% | $313.60K | $250.00K | $357.90K | 43.16% | 02/10/2022 | Get Alert |
| VTGN | VistaGen Therapeutics | -$1.50 | -$1.80 | -$2.10 | -16.67% | $334.00K | $260.00K | $358.00K | 37.69% | 11/10/2021 | Get Alert |
| VTGN | VistaGen Therapeutics | -$2.10 | -$1.50 | -$1.20 | 20.00% | $0.00 | $380.00K | $354.10K | -6.82% | 08/12/2021 | Get Alert |
| VTGN | VistaGen Therapeutics | -$2.10 | -$1.50 | -$9.00 | -500.00% | $0.00 | $230.00K | $441.90K | 92.13% | 06/29/2021 | Get Alert |
| VTGN | VistaGen Therapeutics | -$4.50 | -$1.50 | -$2.10 | -40.00% | $0.00 | $210.00K | $313.60K | 49.33% | 02/11/2021 | Get Alert |
| VTGN | VistaGen Therapeutics | -$3.90 | -$0.60 | -$1.50 | -150.00% | $0.00 | $1.67M | $334.00K | -80.00% | 11/12/2020 | Get Alert |
| VTGN | VistaGen Therapeutics | -$4.50 | -$3.60 | -$2.10 | 41.67% | $0.00 | — | $0.00 | — | 08/13/2020 | Get Alert |
| VTGN | VistaGen Therapeutics | -$0.15 | -$2.40 | -$2.10 | 12.50% | $0.00 | — | $0.00 | — | 06/29/2020 | Get Alert |
| VTGN | VistaGen Therapeutics | -$7.20 | — | -$4.50 | — | $0.00 | — | $0.00 | — | 02/13/2020 | Get Alert |
| VTGN | VistaGen Therapeutics | -$9.00 | — | -$3.90 | — | $0.00 | — | $0.00 | — | 11/07/2019 | Get Alert |
| VTGN | VistaGen Therapeutics | -$6.00 | — | -$4.50 | — | $0.00 | — | $0.00 | — | 08/13/2019 | Get Alert |
Vistagen Therapeutics (VTGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-06-11 | $-0.25 | $-0.37 | 32.4 % |
| Dec 2023 | 2024-02-13 | $-0.22 | $-0.30 | 26.7 % |
| Sep 2023 | 2023-11-09 | $-0.66 | $-0.68 | 2.94 % |
| Dec 2022 | 2023-02-07 | $-1.50 | $-2.10 | 28.6 % |
Vistagen Therapeutics (VTGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-06-11 | $197.30K | $410.00K | -51.9 % |
| Dec 2023 | 2024-02-13 | $411.40K | $540.00K | -23.8 % |
| Sep 2023 | 2023-11-09 | $277.70K | $180.00K | 54.3 % |
| Dec 2022 | 2023-02-07 | $179.60K | $150.00K | 19.7 % |
FAQ
When is Vistagen Therapeutics (NASDAQ:VTGN) reporting earnings?
Vistagen Therapeutics (VTGN) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on June 11, 2024 for Q4.
What were the latest earnings per share (EPS) for Vistagen Therapeutics (NASDAQ:VTGN)?
The Actual EPS was $-0.25, which beat the estimate of $-0.37.
What were Vistagen Therapeutics’s (NASDAQ:VTGN) revenues?
The Actual Revenue was $197.3K, which missed the estimate of $410K.
Browse earnings estimates, EPS, and revenue on all stocks.